News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
114,472 Results
Type
Article (7407)
Company Profile (32)
Press Release (107032)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (33305)
Career Advice (205)
Deals (5183)
Drug Delivery (12)
Drug Development (11350)
Employer Resources (11)
FDA (3100)
Job Trends (3155)
News (54580)
Policy (5870)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (729)
Academic (1)
Accelerated approval (2)
Allergies (19)
Alliances (10931)
ALS (24)
Alzheimer's disease (233)
Antibody-drug conjugate (ADC) (45)
Approvals (3198)
Artificial intelligence (87)
Autoimmune disease (13)
Automation (22)
Bankruptcy (28)
Best Places to Work (2470)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (20)
Bladder cancer (41)
Brain cancer (7)
Breast cancer (130)
Cancer (938)
Cardiovascular disease (43)
Career advice (189)
Career pathing (2)
CAR-T (82)
CDC (2)
Celiac Disease (1)
Cell therapy (174)
Cervical cancer (10)
Clinical research (8954)
Collaboration (368)
Company closure (1)
Compensation (17)
Complete response letters (7)
COVID-19 (740)
CRISPR (27)
C-suite (115)
Cystic fibrosis (29)
Data (1010)
Denatured (1)
Depression (5)
Diabetes (49)
Diagnostics (3363)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (52)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (58)
Earnings (10010)
Editorial (3)
Employer branding (3)
Employer resources (9)
Events (12378)
Executive appointments (151)
FDA (3570)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (186)
Gene editing (47)
Generative AI (6)
Gene therapy (328)
GLP-1 (131)
Government (1014)
Grass and pollen (3)
Guidances (50)
Healthcare (2527)
HIV (13)
Huntington's disease (3)
IgA nephropathy (2)
Immunology and inflammation (11)
Immuno-oncology (8)
Indications (19)
Infectious disease (803)
Inflammatory bowel disease (11)
Inflation Reduction Act (1)
Influenza (32)
Intellectual property (24)
Interviews (28)
IPO (1641)
IRA (2)
Job creations (805)
Job search strategy (176)
JPM (7)
Kidney cancer (1)
Labor market (4)
Layoffs (49)
Leadership (3)
Legal (1156)
Liver cancer (13)
Lung cancer (146)
Lymphoma (78)
Machine learning (9)
Management (3)
Manufacturing (208)
MASH (10)
Medical device (1425)
Medtech (1426)
Mergers & acquisitions (3688)
Metabolic disorders (92)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (46)
Neuropsychiatric disorders (1)
Neuroscience (341)
NextGen: Class of 2026 (900)
Non-profit (620)
Now hiring (15)
Obesity (32)
Opinion (29)
Ovarian cancer (40)
Pain (14)
Pancreatic cancer (25)
Parkinson's disease (26)
Partnered (8)
Patents (45)
Patient recruitment (43)
Peanut (11)
People (10135)
Pharmaceutical (6)
Phase 1 (3111)
Phase 2 (3688)
Phase 3 (3238)
Pipeline (782)
Policy (11)
Postmarket research (402)
Preclinical (1612)
Press Release (28)
Prostate cancer (41)
Psychedelics (2)
Radiopharmaceuticals (44)
Rare diseases (137)
Real estate (2057)
Recruiting (4)
Regulatory (4424)
Reports (8)
Research institute (695)
Resumes & cover letters (21)
Rett syndrome (8)
RNA editing (3)
RSV (12)
Schizophrenia (3)
Series A (32)
Series B (16)
Service/supplier (1)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (46)
Sponsored (10)
Startups (681)
State (1)
Stomach cancer (2)
Supply chain (21)
Tariffs (2)
The Weekly (3)
Vaccines (165)
Venture capital (4)
Weight loss (16)
Women's health (12)
Date
Today (1)
Last 7 days (71)
Last 30 days (292)
Last 365 days (4010)
2026 (356)
2025 (4103)
2024 (5176)
2023 (6183)
2022 (9767)
2021 (10177)
2020 (9678)
2019 (6802)
2018 (5158)
2017 (5566)
2016 (5539)
2015 (6146)
2014 (4852)
2013 (4294)
2012 (4523)
2011 (4607)
2010 (4115)
Location
Africa (135)
Alabama (11)
Alaska (1)
Arizona (45)
Arkansas (3)
Asia (6862)
Australia (1141)
California (1374)
Canada (369)
China (83)
Colorado (68)
Connecticut (50)
Delaware (49)
Europe (16328)
Florida (182)
Georgia (28)
Idaho (6)
Illinois (91)
India (10)
Indiana (76)
Iowa (2)
Japan (73)
Kansas (26)
Kentucky (7)
Louisiana (3)
Maine (27)
Maryland (192)
Massachusetts (941)
Michigan (89)
Minnesota (50)
Missouri (61)
Montana (9)
Nebraska (3)
Nevada (8)
New Hampshire (8)
New Jersey (604)
New Mexico (8)
New York (433)
North Carolina (253)
North Dakota (3)
Northern California (636)
Ohio (98)
Oklahoma (4)
Oregon (4)
Pennsylvania (252)
Puerto Rico (1)
Rhode Island (11)
South America (191)
South Carolina (6)
Southern California (518)
Tennessee (28)
Texas (398)
United States (5582)
Utah (77)
Virginia (20)
Washington D.C. (13)
Washington State (159)
Wisconsin (21)
114,472 Results for "vector laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viral Vectors at the Vanguard: Inside the Future Factory of Gene Therapy
November 25, 2025
·
1 min read
Press Releases
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
January 12, 2026
·
3 min read
Press Releases
Vector Laboratories Launches Glysite™ Explorer in situ PLA Glycan Detection Kit to Advance Functional Proteomics Research
July 16, 2025
·
3 min read
Press Releases
VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS
January 8, 2026
·
3 min read
Sponsored
Viral Vector Manufacturing: Case Studies and Considerations from a CDMO Perspective
Optimization Through Culture, Quality Control and Regulatory Standards
November 3, 2025
·
14 min read
Press Releases
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
November 21, 2025
·
4 min read
Press Releases
Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly
February 20, 2025
·
3 min read
Press Releases
uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its UltraCell(TM) Technology
December 16, 2025
·
3 min read
Press Releases
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery
November 17, 2025
·
3 min read
Business
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Charles River Laboratories International, Inc. today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement.
June 25, 2024
·
4 min read
1 of 11,448
Next
